The full content of Annals is available to subscribers

Subscribe/Learn More  >
Diagnosis and Treatment |

Systemic Effects of Medications Used To Treat Glaucoma

Daniel E. Everitt, MD; and Jerry Avorn, MD
[+] Article, Author, and Disclosure Information

Grant Support: By the National Eye Institute (EY-07715), the Medical Research Service of the Veterans Administration, the John A. Hartford Foundation, and the Food and Drug Administration (FD-0015D).

Requests for Reprints: Daniel E. Everitt, MD, Beth Israel Hospital, Program for the Analysis of Clinical Strategies, 333 Longwood Avenue, Boston, MA 02115.

Current Author Addresses: Drs. Everitt and Avorn: Beth Israel Hospital, Program for the Analysis of Clinical Strategies, 330 Brookline Avenue, Boston, MA 02215.

©1990 American College of PhysiciansAmerican College of Physicians

Ann Intern Med. 1990;112(2):120-125. doi:10.7326/0003-4819-112-2-120
Text Size: A A A

Medications used to treat glaucoma can have clinically important systemic effects in some patients; these effects may not be recognized in elderly patients who have chronic medical problems and who are taking several systemic medications. Beta-blocking ophthalmic agents are generally safe, but can be absorbed systemically to induce bronchospasm, worsen heart block, decompensate congestive heart failure, or create central nervous system effects in some patients. Reports of adverse systemic effects from miotics, such as pilocarpine, are rare, although cardiovascular decompensation has been seen in patients with acute angle closure who were given excessive doses before surgery. Topical sympathomimetic agents such as epinephrine may increase ventricular extrasystoles and have, on occasion, caused severe hypertensive reactions. Nearly 50% of patients taking carbonic anhydrase inhibitors must discontinue their use because of various adverse constitutional and central nervous system symptoms. Although these drugs are not usually part of internal medicine regimens, they can produce adverse effects that mimic primary disease in nonocular organ systems.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.